Pfizer report12 Aug 2025 09:55
This is the bit I like,
These results support the growing evidence that EpiSwitch technology, already utilised in prostate cancer testing, has the potential to revolutionise cancer detection and monitoring across various types of cancer.
The potential is absolutely huge, just need the finance package to get to profitability